Lipid profile and glucose changes after supplementation with astaxanthin: A systematic review and meta-analysis of randomized controlled trials

Archives of Medical Science

Volumn 11, Issue 2, 2015, Pages 253-266

  Ursoniu, Sorin ^a   Sahebkar, Amirhossein ^b   Serban, Maria Corina ^a   Banach, Maciej ^c  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidants; Astaxanthin; Glucose; Lipids

Indexed keywords

ASTAXANTHIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CANADA; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; EFFECT SIZE; FINLAND; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; LIPID BLOOD LEVEL; LIPID METABOLISM; META ANALYSIS; METHODOLOGY; OUTCOME ASSESSMENT; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SERBIA; SOUTH KOREA; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 84928392457     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2015.50960     Document Type: Article

References (55)

1. Zhao ZW, Cai W, Lin YL, et al. Ameliorative effect of astaxanthin on endothelial dysfunction in streptozotocin-induced diabetes in male rats. Arzneimittel-Forschung 2011; 61: 239-46.
2. Boussiba S, Cohen Z, Richmond A, Vonshak A. Procedure for large-scale production of astaxanthin from Haematococcus. Google Patents 2000.
3. Choi HD, Kang HE, Yang SH, Lee MG, Shin WG. Pharmacokinetics and first-pass metabolism of astaxanthin in rats. Br J Nutrition 2011; 105: 220-7.
4. Aoi W, Naito Y, Takanami Y, et al. Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification. Biochem Biophys Res Comm 2008; 366: 892-7.
5. Derosa G, Limas CP, Macías PC, Estrella A, Maffioli P. Dietary and nutraceutical approach to type 2 diabetes. Arch Med Sci 2014; 10: 336.
6. Kavitha K, Kowshik J, Kishore TK, Baba AB, Nagini S. Astaxanthin inhibits NF-kappaB and Wnt/beta-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer. Biochim Biophys Acta 2013; 1830: 4433-44.
7. Kowshik J, Baba AB, Giri H, et al. Astaxanthin inhibits JAK/STAT-3 signaling to abrogate cell proliferation, invasion and angiogenesis in a hamster model of oral cancer. PLoS One 2014; 9: e109114.
8. Palozza P, Torelli C, Boninsegna A, et al. Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells. Cancer Lett 2009; 283: 108-17.
9. Choi HD, Youn YK, Shin WG. Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects. Plant Foods Hum Nutrition 2011; 66: 363-9.
10. Wolf AM, Asoh S, Hiranuma H, et al. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J Nutr Biochem 2010; 21: 381-9.
11. Sahebkar A, Serban C, Ursoniu S, Banach M. Effect of curcuminoids on oxidative stress: a systematic review and meta-analysis of randomized controlled trials. J Funct Foods 2015; (in press), DOI: 10.1016/j.jff.2015.01.005.
12. Lauver DA, Driscoll EM, Lucchesi BR. Disodium disuccinate astaxanthin prevents carotid artery rethrombosis and ex vivo platelet activation. Pharmacology 2008; 82: 67-73.
13. Gross GJ, Lockwood SF. Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (〈 i〉 Cardax〈/i〉™). Life Sci 2004; 75: 215-24.
14. Gross GJ, Hazen SL, Lockwood SF. Seven day oral supplementation with Cardax TM (disodium disuccinate astaxanthin) provides significant cardioprotection and reduces oxidative stress in rats. Mol Cell Biochem 2006; 283: 23-30.
15. Hussein G, Nakamura M, Zhao Q, et al. Antihypertensive and neuroprotective effects of astaxanthin in experimental animals. Biol Pharm Bull 2005; 28: 47-52.
16. Hussein G, Goto H, Oda S, Sankawa U, Matsumoto K, Watanabe H. Antihypertensive potential and mechanism of action of astaxanthin: III. Antioxidant and histopathological effects in spontaneously hypertensive rats. Biol Pharm Bull 2006; 29: 684-8.
17. Banach M, Serban C, Aronow WS, et al. Lipid, blood pressure and kidney update 2013. Int Urol Nephrol 2014; 46: 947-61.
18. Lee DH, Lee YJ, Kwon KH. Neuroprotective effects of astaxanthin in oxygen-glucose deprivation in SH-SY5Y cells and global cerebral ischemia in rat. J Clin Biochem Nutrition 2010; 47: 121-9.
19. Kristinsson HG, Miyashita K. Marine antioxidants. Polyphenols and carotenoids from algae. In: Antioxidants and Functional Components in Aquatic Foods. Edited by: Hordur G. Kristinsson. John Wiley & Sons, Ltd. 2014.
20. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Bioch Cell Biol 2007; 39: 44-84.
21. Bohn T. Bioavailability of non-provitamin A carotenoids. Curr Nutr Food Sci 2008; 4: 240-58.
22. McNulty HP, Byun J, Lockwood SF, Jacob RF, Mason RP. Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis. Biochim Biophys Acta 2007; 1768: 167-74.
23. Jia Y, Kim JY, Jun HJ, et al. The natural carotenoid astaxanthin, a PPAR-alpha agonist and PPAR-gamma antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes. Mol Nutrition Food Res 2012; 56: 878-88.
24. Liu PH, Aoi W, Takami M, et al. The astaxanthin-induced improvement in lipid metabolism during exercise is mediated by a PGC-1alpha increase in skeletal muscle. J Clin Biochem Nutrition 2014; 54: 86-9.
25. Ikeuchi M, Koyama T, Takahashi J, Yazawa K. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem 2007; 71: 893-9.
26. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.0. 2 (updated September, 2009). The Cochrane Collaboration, 2009. www cochrane-handbook org/(accessed 18 May 2009). 2010.
27. Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive meta-analysis version 2. Englewood, NJ: Biostat 2005; 104.
28. Sahebkar A. Does PPARgamma2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis. DNA Cell Biol 2013; 32: 188-98.
29. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res 2014; 28: 633-42.
30. Duval S, Tweedie R. Trim and fill: a simple funnel-plotbased method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-63.
31. Karppi J, Rissanen TH, Nyyssönen K, et al. Effects of astaxanthin supplementation on lipid peroxidation. Int J Vitam Nutr Res 2007; 77: 3-11.
32. Yang Y, Seo JM, Nguyen A, et al. Astaxanthin-rich extract from the green alga Haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense in apolipoprotein E knockout mice. J Nutr 2011; 141: 1611-7.
33. Yoshida H, Yanai H, Ito K, et al. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis 2010; 209: 520-3.
34. Iizuka M, Ayaori M, Uto-Kondo H, et al. Astaxanthin enhances ATP-binding cassette transporter A1/G1 expressions and cholesterol efflux from macrophages. J Nutr Sci Vitaminol 2012; 58: 96-104.
35. Jia Y, Kim JY, Jun HJ, et al. The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-gamma antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes. Mol Nutr Food Res 2012; 56: 878-88.
36. Yang Y, Pham TX, Wegner CJ, et al. Astaxanthin lowers plasma TAG concentrations and increases hepatic antioxidant gene expression in diet-induced obesity mice. Br J Nutr 2014; 112: 1797-804.
37. Jacobsson LS, Yuan XM, Ziedén B, Olsson AG. Effects of alpha-tocopherol and astaxanthin on LDL oxidation and atherosclerosis in WHHL rabbits. Atherosclerosis 2004; 173: 231-7.
38. Iwamoto T, Hosoda K, Hirano R, et al. Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb 1999; 7: 216-22.
39. Kishimoto Y, Tani M, Uto-Kondo H, et al. Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophages. Eur J Nutr 2010; 49: 119-26.
40. Uchiyama K, Naito Y, Hasegawa G, Nakamura N, Takahashi J, Yoshikawa T. Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice. Redox Rep 2002; 7: 290-3.
41. Bhuvaneswari S, Anuradha CV. Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. Can J Physiol Pharmacol 2012; 90: 1544-52.
42. Bhuvaneswari S, Yogalakshmi B, Sreeja S, Anuradha CV. Astaxanthin reduces hepatic endoplasmic reticulum stress and nuclear factor-kappaB-mediated inflammation in high fructose and high fat diet-fed mice. Cell Stress and Chaperones 2014; 19: 183-91.
43. Ishiki M, Nishida Y, Ishibashi H, et al. Impact of divergent effects of astaxanthin on insulin signaling in l6 cells. Endocrinology 2013; 154: 2600-12.
44. Naito Y, Uchiyama K, Aoi W, et al. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors 2004; 20: 49-59.
45. Okada Y, Ishikura M, Maoka T. Bioavailability of astaxanthin in Haematococcus algal extract: the effects of timing of diet and smoking habits. Biosci Biotechnol Biochem 2009; 73: 1928-32.
46. Comhaire F, Garem YE, Mahmoud A, Eertmans F, Schoonjans F. Combined conventional/antioxidant "Astaxanthin" treatment for male infertility: a double blind, randomized trial. Asian J Androl 2005; 7: 257-62.
47. Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol 2003; 21: 210-6.
48. Tetens I. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the safety of astaxanthin-rich ingredients (AstaREAL A1010 and AstaREAL L10) as novel food ingredients. Europen Food Safety Authority, 2014.
49. Baralic I, Djordjevic B, Dikic N, et al. Effect of astaxanthin supplementation on paraoxonase 1 activities and oxidative stress status in young soccer players. Phytother Res 2013; 27: 1536-42.
50. Karppi J, Rissanen TH, Nyyssonen K, et al. Effects of astaxanthin supplementation on lipid peroxidation. Int J Vitam Nutr Res 2007; 77: 3-11.
51. MacDermid JC, Vincent JI, Gan BS, Grewal R. A blinded placebo-controlled randomized trial on the use of astaxanthin as an adjunct to splinting in the treatment of carpal tunnel syndrome. Hand 2012; 7: 1-9.
52. Nakagawa K, Kiko T, Miyazawa T, et al. Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes. Br J Nutr 2011; 105: 1563-71.
53. Saito M, Yoshida K, Saito W, et al. Astaxanthin increases choroidal blood flow velocity. Graefes Arch Clin Exp Ophthalmol 2012; 250: 239-45.
54. Serban C, Sahebkar A, Antal D, Ursoniu S, Banach M. Effects of supplementation with green tea catechins on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. Nutrition 2015; DOI: 10.1016/j.nut.2015.02.004
55. Banach M, Aronow WS, Serban C, et al. Lipids, blood pressure and kidney update 2014. Pharmacol Res 2015; 95-96C: 111-25.